Investing Profile

David Fallace

InvestorVCFounder
Managing Partner and Co-Founder at Cure Ventures
curevc.comMassachusetts
Photo of David Fallace, Managing Partner at Cure Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Cure Ventures Managing Partner
$100K - $5.0M
$1.5M
1
CompanyStageDateRound SizeTotal Raised
Kenai Therapeutics
Series AFeb 2024$82M
$82M
Co-investors: Jeff Goater (The Column Group)